Ching has more than 25 years of clinical development experience at global biopharmaceutical companies and leading CROs. She has built and led functions in Statistical Programming, Data Management, Pharmacovigilance Innovation, and Early Clinical Operations. Driven by her passion for optimizing the clinical development processes through technology, Ching spearheaded enterprise technology initiatives as both an early adopter and a co-creator.
Ching’s journey on decentralized clinical trials started at Novartis in 2017 as the head of the Global Drug Development DCT initiative. She developed the flexible modular solution strategy and led the implementation, emphasizing the hybrid trial model enablement. At Medable, she drives DCT product strategy to increase the patient-centric trial model adoption through user-friendly and compliant digital solutions.